Synthesis and Immunological Evaluation of Pentamannose-Based HIV-1 Vaccine Candidates
Synthesis and Immunological Evaluation of Pentamannose-Based HIV-1 Vaccine Candidates
复制标题
基于五甘露糖的 HIV-1 候选疫苗的合成和免疫学评价
DOI:
10.1021/acs.bioconjchem.2c00079
复制
发表时间:
2022-05-18
影响因子:
4.7
通讯作者:
Ye,Xin-Shan
中科院分区:
文献类型:
--
作者:
Liu,Chang-Cheng;Huo,Chang-Xin;Ye,Xin-Shan
Dense glycosylation and the trimeric conformation of the human immunodeficiency virus-1 (HIV-1) envelope protein limit the accessibility of some cellular glycan processing enzymes and end up with high-mannose-typeN-linked glycans on the envelope spike, among which the Man5GlcNAc2structure occupies a certain proportion. The Man5GlcNAc2glycan composes the binding sites of some potent broadly neutralizing antibodies, and some lectins that can bind Man5GlcNAc2show HIV-neutralizing activity. Therefore, Man5GlcNAc2is a potential target for HIV-1 vaccine development. Herein, a highly convergent and effective strategy was developed for the synthesis of Man5and its monofluoro-modified, trifluoro-modified, andS-linked analogues. We coupled these haptens to carrier protein CRM197 and evaluated the immunogenicity of the glycoconjugates in mice. The serological assays showed that the native Man5conjugates failed to induce Man5-specific antibodiesin vivo, while the modified analogue conjugates induced stronger antibody responses. However, these antibodies could not bind the native gp120 antigen. These results demonstrated that the immune tolerance mechanism suppressed the immune responses to Man5-related structures and the conformation of glycan epitopes on the synthesized glycoconjugates was distinct from that of native glycan epitopes on gp120.